Pfizer walks away from its $150 billion Allergan deal

Pfizer is walking away from the $150 billion deal to buy Allergan, after the Obama administration took aim to stop the biggest U.S. drug company to move to Ireland to lower its taxes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.